# Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial

> **NCT07699107** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Nisha Acharya** · enrollment: 160 (estimated)

## Conditions studied

- Juvenile Idiopathic Arthritis Associated Uveitis
- Uveitis, Anterior

## Interventions

- **BIOLOGICAL:** Adalimumab/Biosimilar

## Key facts

- **NCT ID:** NCT07699107
- **Lead sponsor:** Nisha Acharya
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2030-05
- **Final completion:** 2030-11
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-07-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699107, "Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07699107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*